LifeScienceHistory.com - Check us out on Instagram
Videoconferencing
The Food and Drug Administration's Center for Drug Evaluation and Research has installed state-of-the-art
videoconferencing technology for communicating with employees inside the organization as well as with industry
representatives, consumers, healthcare professionals, academia, and other government agencies.
CDER's videoconferencing enhances face-to-face meetings by allowing participants the opportunity to listen, watch
and participate "live" in a normal two-way conversation.
Videoconferencing can be used for such diverse purposes as:
- delivering a speech to an overseas audience from CDER facilities;
- "attending" a committee meeting being held in another city;
- interviewing prospective new employees;
- "attending" a training session being held in another city;
- holding a product review meeting with a division located in another CDER building.
CDER currently has videoconferencing capabilities in the Parklawn building, Woodmont Office Complex II, and Corporate
Boulevard building.
For more information on the Center's videoconferencing capabilities or to schedule an event, telephone CDER's Office of
Training and Communications at (301) 827-1243.
Source: U.S. Food and Drug Administration Center for Drug Evaluation and Research Handbook.
Back to The New Drug Development Process